Nymox Pharmaceutical
NYMX
#9909
Rank
NZ$30.5 M
Marketcap
Country
$0.33
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -NZ$3.76 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$10.91 Million, an increase over its 2021 earnings that were of -NZ$20.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$3.76 Million-65.54%
2022 -NZ$10.91 Million-47.71%
2021 -NZ$20.87 Million6.61%
2020 -NZ$19.57 Million-10.91%
2019 -NZ$21.97 Million24.24%
2018 -NZ$17.68 Million-20.03%
2017 -NZ$22.11 Million2.71%
2016 -NZ$21.53 Million-63.86%
2015 -NZ$59.56 Million674.44%
2014 -NZ$7.7 Million-6.11%
2013 -NZ$8.2 Million-35.66%
2012 -NZ$12.74 Million-20.76%
2011 -NZ$16.07 Million38.33%
2010 -NZ$11.62 Million35.59%
2009 -NZ$8.57 Million11.8%
2008 -NZ$7.67 Million-12.94%
2007 -NZ$8.81 Million8.85%
2006 -NZ$8.09 Million36.5%
2005 -NZ$5.93 Million-4.4%
2004 -NZ$6.2 Million-14.58%
2003 -NZ$7.26 Million
2001 -NZ$5.33 Million-20.54%
2000 -NZ$6.7 Million21.72%
1999 -NZ$5.51 Million-25.56%
1998 -NZ$7.4 Million101.3%
1997 -NZ$3.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$11.72 B-324,625.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.57 B-514,352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.96 B-54,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.19 B-586,883.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.15 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA